熱門資訊> 正文
Biodexa Pharmaceuticals GAAP每股收益为-£0.0002
2025-09-12 20:43
- Biodexa Pharmaceuticals press release (NASDAQ:BDRX): 1H GAAP EPS of -£0.0002.
- Net cash used in operating activities (after changes in working capital) in 1H25 was £3.30 million (1H24: £4.81 million).
- The company’s cash balance at June 30, 2025 was £4.04 million.
More on Biodexa Pharmaceuticals
- Seeking Alpha’s Quant Rating on Biodexa Pharmaceuticals
- Historical earnings data for Biodexa Pharmaceuticals
- Financial information for Biodexa Pharmaceuticals
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
